Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
1051375-16-6
Name
Dolutegravir
Synonyms
(
4R,12aS)-N-(2,4-Difluorbenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazin-9-carboxamid [German] [
ACD/
IUPAC Name] (
4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide [
ACD/
IUPAC Name] (
4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-méthyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide [French] [
ACD/
IUPAC Name] (
4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide 1051375-16-6 [
RN] 2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (
4R,12aS)- [
ACD/Index Name] 9261
DKO1W9H7M1 Dolutegravir [
INN] [
USAN] [Wiki] Dolutegravir [Spanish] [
INN] Dolutégravir [French] [
INN] Dolutegravirum [Latin] [
INN]
GSK 1349572 S-349572 (
3S,
7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide (
3S,
7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0³,â¸]tetradeca-10,13-diene-13-carboxamide (
4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-a]pyrido[1,2-d]pyrazine-9-carboxamide (
4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1 ,3]oxazine-9-carboxamide (
4R,12aS)-N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide (
4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide [1051375-16-6] 1051375-19-9 [
RN]
DLU Dolutegravir (
GSK1349572) Dolutegravir(S/
GSK1349572) dolutegravir/
GSK1349572/S-349572
GSK 1349572|
GSK-1349572|
GSK1349572|S-349572|Tivicay®
GSK1349572 GSK-1349572 MFCD20488027 S/
GSK 1349572 S/
GSK1349572 S/
GSK1349572 (
GSK1349572) S/
GSK1349572 ;
GSK1349572;S/
GSK 1349572 ;
GSK-1349572 ;
GSK 1349572 Tivicay [Trade name] Tivicay®
UNII :
DKO1W9H7M1 UNII-DKO1W9H7M1 Molecular Structure
Structure of Dolutegravir CAS 1051375-16-6
SMILES
C[C@@H]
1CCO[C@@H]
2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)O
StdInChI
InChI=
1S/
C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,
27H,4-5,7,
9H2,
1H3,(H,23,28)/t10-,15+/m1/s1
StdInChIKey
RHWKPHLQXYSBKR-BMIGLBTASA-N Molecular Formula
C20H19F2N3O5 Molecular Weight
419.3787664
Safety Data
WGK Germany
3
Specifications and Other Information of Our Dolutegravir CAS 1051375-16-6
Standard
Enterprise standard
Purity
99%min
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Used as the new drug of Anti-AIDS.
Links
This product is developed by our R
&D company Watsonnoke Scientific Ltd(
http://www.watsonnoke.com/), and here is the corresponding link
http://www.watsonnoke.com/dolutegravir-cas-1051375-16-6/”
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).